MTI084: Ty Crandall on Business Funding
Investing in your business is investing in yourself. A business can contribute to your retirement as an asset you could either sell or create an income for years to come. Our guest, Ty Crandall, belie...
29 Apr 201637min
MTI083: Adaptive Asset Allocation with Adam Butler
Adam Butler is CFA and CEO of ReSolve Asset Management. He co-wrote a book, Adaptive Asset Allocation, with Michael Philbrick and Rodrigo Gordillo. Adaptive asset allocation is a form of market rotati...
22 Apr 20161h 3min
MTI082: Terrance Odean – Making Simple Smart Financial Decisions
In this complex world of finance, we need to keep these main areas simple: Saving, insurance and investing 1. Saving, Spending, and Credit If you aren't saving enough you are probably spending too muc...
15 Apr 201647min
MTI081: Build Wealth, Not a Credit Score with Steve Stewart
Can you be credit worthy without a credit score? That's what Financial Wellness Coach, Steve Stewart, believes. A credit score is based on your credit report – but the only things on credit reports ar...
8 Apr 201653min
MTI080: Safety Scores with Kevin Stewart
Kevin Stewart introduced the Safety Score to StocksForTheWeek.com. The Safety Score looks at the typical income statement items a financial analyst would use to come up with a score for more than 2,40...
1 Apr 201626min
MTI079: Listener Questions on ETF Arbitrage, Index Funds, and Pay Down Mortgage or Invest
We are back with questions from YOU. Today's topics cover picking ETFs, investing in index funds, and should you pay extra on the mortgage or invest Read more › The post MTI079: Listener Questi...
25 Mar 201643min
MTI078: Pessimistic About the Market? David Holland rests our fears
If advisers can list the serious risks of the market, like the drop in oil prices or possibility the Fed makes a bad decision, how can they still say "Don't worry. It'll be OK and you should still inv...
18 Mar 201639min
MTI077: Biotech Sector Investing with Brad Loncar
Biotechnology has been the stock market's best performing sector over the last 4-5 years, according to Brad Loncer, a private investor with a biotech focus. Cancer immunotherapy caught his attention. ...
11 Mar 201641min
